Clinical Trial Update: Ultrasound-Enhanced Delivery of Compound TXA Solution in Melasma [NA]

View source ↗

Summary

A clinical trial update notes that ultrasound-enhanced delivery of a tranexamic acid solution (Compound TXA) is being studied for facial melasma, and the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Compound TXA Solution (Tranexamic acid)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Melasma (Facial Melasma) | NA | Status: RECRUITING